Moderna and OpenAI Collaborate To Advance mRNA Medicine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Morgan Stanley Comments on Moderna (MRNA) Collaboration with OpenAI
April 24, 2024 12:31 PM EDTMorgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $89.00 price target on Moderna (NASDAQ: MRNA)
The analyst comments "MRNA announced an update regarding the company's ongoing collaboration with OpenAI (privately held) on generative AI tools, noting that the ChatGPT Enterprise is embedded across MRNA's business functions and has achieved more than 80% internal adoption throughout... More
